Competition Markets Authority
Statutory timetable
| Date | Action |
|---|---|
| 19 March 2024 | Deadline for phase 1 decision (*) |
| 23 January 2024 | Launch of merger inquiry |
| 28 November 2023 | Initial enforcement order |
(*) This date is the current statutory deadline by when the decision will be announced. If any change occurs, the information is refreshed as soon as practicable. However, the CMA cannot guarantee that the decision will be announced on or before this current deadline, as the deadline of a given case may change during the merger assessment process due to different reasons.
Phase 1
Launch of merger inquiry
23 January 2024: The CMA announced the launch of its merger inquiry by notice to the parties.
- (23.1.24)
Invitation to comment: closed on 6 February 2024
23 January 2024: The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this merger has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
To assist it with this assessment, the CMA invites comments on the transaction from any interested party.
These comments should be provided by the deadline set out above.
Initial enforcement order
28 November 2023: The Competition and Markets Authority has served an initial enforcement order under section 72(2) of the Enterprise Act 2002 on Pharmacy2U, P2U Holdings Limited, G Square Capital II L.P., G Square Healthcare Private Equity LLP and Lloyds Direct.
- (30.11.23)
Amendments / consents granted
- (23.1.24)
- (30.11.23)
Contact
Please send written representations about any competition or public interest issues to:
Pharmacy2ULloydsdirect@cma.gov.uk
Your name and contact details are your personal data. In collecting, receiving, storing, accessing and using your personal data, the CMA, as controller, is processing your personal data. The CMA processes personal data in accordance with data protection law. The CMA is processing your personal data so that it can contact you again, should it need further help or information from you, in order to carry out its merger work under Part 3 of the Enterprise Act 2002. For more information about how the CMA processes personal data and your rights relating to that data, please see our Privacy Notice.